Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Talking Therapeutics

New Option Emerges for Statin-intolerant Patients

07/18/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

“Bempedoic acid, an ATP citrate lyase inhibitor, can reduce LDL levels and was shown in a randomized trial to reduce rates of major adverse cardiovascular events in statin-intolerant patients,” explains Dr Jennings.

“Bempedoic acid, an ATP citrate...

07/18/2023

Pharmacy Learning Network

Talking Therapeutics

More COVID-19 Vaccine Updates: How Effective Are New Boosters?

01/12/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the latest installment of Talking Therapeutics, Dr Jennings explores the efficacy of the new bivalent boosters against several strains of COVID-19.

In the latest installment of...

01/12/2023

Pharmacy Learning Network

Talking Therapeutics

An ACE in the Hole No More

08/10/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

This week, Dr Jennings reviews a recent paper published online in Hypertension that examined the effectiveness and safety of ACE inhibitors and angiotensin receptor blockers as a first-line therapy option for the management of hypertension.

This week, Dr Jennings reviews a...

08/10/2021

Pharmacy Learning Network

Talking Therapeutics

ACC.22 Update: Exercise Capacity, Hyperkalemia, and Cholesterol

04/07/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings highlights new data presented at ACC.22, focusing on the efficacy of 3 agents in preventing hyperkalemia events, reducing cholesterol, and more.

Dr Jennings highlights new data...

04/07/2022

Pharmacy Learning Network

Talking Therapeutics

AHA Scientific Sessions 2022 Update, Part 1

11/10/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the latest issue of Talking Therapeutics, Dr Jennings highlights data from American Heart Association Scientific Sessions 2022, including research into direct oral anticoagulants, a novel fibrate, and more.

In the latest issue of Talking...

11/10/2022

Pharmacy Learning Network

Talking Therapeutics

Revealing the Silent Threat: Cardiovascular Disease in Young Adults and the Pursuit of Preventive Measures Through the PRECAD Study

12/11/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week’s installment of Talking Therapeutics, Dr Jennings discusses how cardiovascular disease can affect younger patients and how health care professionals can take the initiative to reach a diagnosis.

In this week’s installment of...

12/11/2023

Pharmacy Learning Network

Talking Therapeutics

Avoiding Scary Cardiovascular Drug Toxicities

10/27/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week's installment of Talking Therapeutics, Dr Jennings discusses data surrounding cardiovascular toxicity of commonly used medications such as stimulants and CAR-T therapy.

In this week's installment of...

10/27/2021

Pharmacy Learning Network

Talking Therapeutics

Fighting for Better Access to Life-Saving Heart Failure Therapies

06/23/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Citing new data on Medicare out-of-pocket costs and prior authorization requirements, Dr Jennings emphasizes reducing financial barriers that could prevent patient access to heart failure therapies.

Citing new data on Medicare...

06/23/2022

Pharmacy Learning Network

Talking Therapeutics

Dispelling the Myth of Alcohol and Heart Disease

04/06/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings discusses findings from a new meta-analysis in which investigators analyzed the impact of alcohol consumption on cardiovascular health across more than 4.8 million study participants.

Dr Jennings discusses findings...

04/06/2023

Pharmacy Learning Network

Talking Therapeutics

A New Standard for Calcium Replacement in Pregnancy

03/14/2024

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluated a simplified calcium administration plan to prevent hypertensive-related pregnancy complications.

In this installment of Talking...

03/14/2024

Pharmacy Learning Network